Want to see AONC full AI Analyst Report?
American Oncology Network (AONC) Ratios
American Oncology Network Ratios
AONC's free cash flow for Q4 2024 was $5.60M. For the 2024 fiscal year, AONC's free cash flow was decreased by $-6.33M and operating cash flow was $11.93M. See a summary of the company’s cash flow.
| Ratios | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.53 | 1.64 | 1.72 | 1.75 | 1.01 |
| Quick Ratio | 1.25 | 1.38 | 1.46 | 1.46 | 1.01 |
| Cash Ratio | 0.29 | 0.17 | 0.19 | 0.23 | 1.01 |
| Solvency Ratio | 0.04 | 0.04 | 0.07 | 0.27 | 1029.68 |
| Operating Cash Flow Ratio | -0.02 | -0.11 | -0.05 | -0.22 | 1497.65 |
| Short-Term Operating Cash Flow Coverage | -1.32 | -2.30 | -0.71 | 0.00 | 0.00 |
| Net Current Asset Value | $ -30.85M | $ -25.94M | $ -22.19M | $ 186.02M | $ 131.00 |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.31 | 0.34 | 0.39 | 0.26 | 0.00 |
| Debt-to-Equity Ratio | 7.85 | -0.79 | 2.05 | 0.20 | 0.00 |
| Debt-to-Capital Ratio | 0.89 | -3.84 | 0.67 | 0.17 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.82 | -0.99 | 0.56 | 0.17 | 0.00 |
| Financial Leverage Ratio | 25.06 | -2.32 | 5.26 | 0.79 | 2.03 |
| Debt Service Coverage Ratio | -0.06 | -2.78 | 1.77 | 5.21 | 23.95 |
| Interest Coverage Ratio | -2.47 | -7.66 | 1.63 | 0.64 | 19.78 |
| Debt to Market Cap | 1.31 | 2.24 | 0.21 | 0.16 | 0.00 |
| Interest Debt Per Share | 11.26 | 20.15 | 3.13 | 1.56 | 0.04 |
| Net Debt to EBITDA | 46.57 | -2.54 | 4.34 | 4.63 | -0.00 |
| Profitability Margins | |||||
| Gross Profit Margin | 6.70% | 6.47% | 8.30% | 8.26% | 9.12% |
| EBIT Margin | -1.00% | -4.38% | 0.52% | 0.19% | 3.07% |
| EBITDA Margin | 0.10% | -3.08% | 2.01% | 0.83% | 3.58% |
| Operating Profit Margin | -0.99% | -3.84% | 0.48% | 0.10% | 3.05% |
| Pretax Profit Margin | -1.39% | -4.89% | 0.23% | 0.04% | 2.92% |
| Net Profit Margin | -0.23% | -0.43% | 0.23% | -0.01% | 3.03% |
| Continuous Operations Profit Margin | -1.53% | -4.92% | 0.23% | -0.01% | 3.03% |
| Net Income Per EBT | 16.24% | 8.87% | 100.00% | -29.58% | 103.70% |
| EBT Per EBIT | 140.34% | 127.17% | 46.51% | 38.97% | 95.90% |
| Return on Assets (ROA) | -0.84% | -1.48% | 0.79% | -0.04% | 44765.98% |
| Return on Equity (ROE) | -21.17% | 3.43% | 4.17% | -0.03% | 90834.23% |
| Return on Capital Employed (ROCE) | -6.88% | -23.93% | 3.00% | 0.71% | 91334.93% |
| Return on Invested Capital (ROIC) | -6.56% | -22.22% | 2.72% | -0.21% | 91334.93% |
| Return on Tangible Assets | -0.87% | -1.48% | 0.80% | -0.04% | 44765.98% |
| Earnings Yield | -5.72% | -14.05% | 0.62% | -0.03% | 7.66% |
| Efficiency Ratios | |||||
| Receivables Turnover | 9.28 | 7.75 | 6.92 | 6.83 | 0.00 |
| Payables Turnover | 9.62 | 9.37 | 9.90 | 9.32 | 0.00 |
| Inventory Turnover | 27.04 | 26.84 | 28.90 | 25.07 | 0.00 |
| Fixed Asset Turnover | 17.86 | 15.27 | 15.19 | 28.91 | 0.00 |
| Asset Turnover | 3.74 | 3.42 | 3.52 | 3.80 | 14780.12 |
| Working Capital Turnover Ratio | 15.75 | 12.19 | 12.10 | 21.22 | 0.00 |
| Cash Conversion Cycle | 14.87 | 21.74 | 28.49 | 28.81 | 0.00 |
| Days of Sales Outstanding | 39.34 | 47.09 | 52.73 | 53.42 | 0.00 |
| Days of Inventory Outstanding | 13.50 | 13.60 | 12.63 | 14.56 | 0.00 |
| Days of Payables Outstanding | 37.96 | 38.94 | 36.87 | 39.17 | 0.00 |
| Operating Cycle | 52.84 | 60.69 | 65.36 | 67.97 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.36 | -2.71 | -0.16 | -0.63 | 1.25 |
| Free Cash Flow Per Share | -1.89 | -4.55 | -0.34 | -0.83 | 0.84 |
| Dividend Paid and CapEx Coverage Ratio | -0.24 | -1.48 | -0.94 | -3.16 | 3.05 |
| Capital Expenditure Coverage Ratio | -0.24 | -1.48 | -0.94 | -3.16 | 3.05 |
| Operating Cash Flow Coverage Ratio | -0.03 | -0.14 | -0.05 | -0.41 | 0.00 |
| Operating Cash Flow to Sales Ratio | -0.00 | -0.01 | -0.01 | -0.03 | 0.05 |
| Free Cash Flow Yield | -37.31% | -77.07% | -3.34% | -8.53% | 8.73% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -17.47 | -7.12 | 161.82 | -3871.03 | 13.06 |
| Price-to-Sales (P/S) Ratio | 0.04 | 0.03 | 0.36 | 0.43 | 0.40 |
| Price-to-Book (P/B) Ratio | 3.70 | -0.24 | 6.76 | 1.30 | 11862.35 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.68 | -1.30 | -29.98 | -11.73 | 11.46 |
| Price-to-Operating Cash Flow Ratio | -14.04 | -2.18 | -61.76 | -15.43 | 7.70 |
| Price-to-Earnings Growth (PEG) Ratio | 0.35 | 0.00 | -0.06 | 38.58 | 0.00 |
| Enterprise Value Multiple | 84.81 | -3.54 | 22.49 | 56.39 | 11.05 |
| Enterprise Value | 153.93M | 139.23M | 519.17M | 442.80M | 286.64M |
| EV to EBITDA | 84.81 | -3.54 | 22.49 | 56.39 | 11.05 |
| EV to Sales | 0.09 | 0.11 | 0.45 | 0.47 | 0.40 |
| EV to Free Cash Flow | -5.94 | -4.58 | -37.14 | -12.78 | 11.45 |
| EV to Operating Cash Flow | -31.14 | -7.68 | -76.53 | -16.81 | 7.70 |
| Tangible Book Value Per Share | 6.90 | 10.39 | 1.46 | 5.40 | 0.00 |
| Shareholders’ Equity Per Share | 1.37 | -24.19 | 1.49 | 7.50 | 0.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.10 | -0.01 | 0.00 | 1.30 | -0.04 |
| Revenue Per Share | 128.27 | 191.32 | 27.58 | 22.64 | 24.27 |
| Net Income Per Share | -0.29 | -0.83 | 0.06 | -0.00 | 0.74 |
| Tax Burden | 0.16 | 0.09 | 1.00 | -0.30 | 1.04 |
| Interest Burden | 1.39 | 1.11 | 0.43 | 0.20 | 0.95 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.08 | 0.08 | 0.08 | 0.08 | 0.06 |
| Stock-Based Compensation to Revenue | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.18 | 0.29 | -2.62 | 250.84 | 1.70 |
Currency in USD